Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-12-17 | Cullinan Oncology | Series C | $131.2M | Baupost Group, Boxer Capital, BVF Partners, Cowen, Eventide Asset Management, Foresite Capital, Logos Capital, MPM Capital, Nextech Invest, OrbiMed Advisors, Rock Springs Capital, Schooner Capital, Undisclosed Angel Investors, and Venrock |
2020-06-10 | COI Pharamaceuticals | Unattributed VC | $16.59M | Avalon Ventures |
2020-06-04 | Cullinan Oncology | Series B | $98.5M | MPM Capital, and Undisclosed Investors |
2020-03-30 | ElevateBio | Series B | $170M | EcoR1 Capital, EDBI, Invus Group, MPM Capital, Redmile Group, Samsara BioCapital, Surveyor Capital, and Vertex Ventures |
2019-05-22 | Allovir | Series B | $120M | EcoR1 Capital, Fidelity Investments, Gilead Sciences, Invus Group, Redmile Group, Samsara BioCapital, and SVB Leerink |